# Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence

> **NCT03127995** · NA · ACTIVE_NOT_RECRUITING · sponsor: **UNICANCER** · enrollment: 1265 (actual)

## Conditions studied

- Breast Cancer Female

## Interventions

- **RADIATION:** HYPOFRACTIONATED
- **RADIATION:** NORMOFRACTIONATED

## Key facts

- **NCT ID:** NCT03127995
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-09
- **Primary completion:** 2022-12-31
- **Final completion:** 2030-09
- **Target enrollment:** 1265 (ACTUAL)
- **Last updated:** 2024-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03127995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03127995, "Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03127995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*